Related Experiment Videos

Cardiovascular profile of 5-methyl-2-phenyl-4-imidazole-acetonitrile (MCN-2378), a cerebral vasodilator

Insights

McN-2378 preferentially increases cerebral blood flow in monkeys, independent of theta-adrenergic blockade. In dogs, it caused transient hypotension and increased cardiac output, without evidence of cyanide release.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cardiovascular Physiology

Background:

  • Cerebral blood flow regulation is crucial for brain function.
  • Understanding novel vasodilators is important for treating cerebrovascular disorders.
  • McN-2378 is a compound with potential vasodilatory properties.

Purpose of the Study:

  • To investigate the effects of McN-2378 on cerebral and systemic blood flow.
  • To determine the influence of theta-adrenergic blockade on McN-2378's cerebral effects.
  • To assess the cardiovascular effects of McN-2378 in an anesthetized model.

Main Methods:

  • Intravenous administration of McN-2378 in two strains of monkeys.
  • Measurement of cerebral and femoral blood flow.
  • Administration of theta-adrenergic blockade in monkeys.
  • Assessment of systemic arterial pressure, femoral vascular resistance, heart rate, and cardiac output in anesthetized dogs.

Main Results:

  • McN-2378 preferentially increased cerebral blood flow over femoral blood flow in monkeys.
  • Cerebral vasodilation induced by McN-2378 was unaffected by theta-adrenergic blockade.
  • In dogs, McN-2378 caused transient hypotension, decreased femoral vascular resistance, and increased heart rate and cardiac output.
  • No evidence suggested cyanide release mediated the cerebral vasodilation.

Conclusions:

  • McN-2378 demonstrates selective cerebral vasodilation.
  • The mechanism of cerebral vasodilation is not mediated by theta-adrenergic pathways.
  • McN-2378 exhibits transient cardiovascular effects in dogs, with no indication of cyanide toxicity.

Related Concept Videos